Go to:
Logótipo
You are here: Start > Publications > View > Quality of Vancomycin for Injection Formulations in Brazil
Today is sunday
Horário de verão da Biblioteca
Publication

Quality of Vancomycin for Injection Formulations in Brazil

Title
Quality of Vancomycin for Injection Formulations in Brazil
Type
Article in International Scientific Journal
Year
2019
Authors
Secco, G
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Sachetti, C
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Rossato Grando, LG
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Hahn, SR
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Pagnussat, LR
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Bertol, CD
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Journal
Vol. 15
Pages: 280-285
ISSN: 1573-4129
Publisher: Bentham
Indexing
Publicação em ISI Web of Knowledge ISI Web of Knowledge - 0 Citations
Publicação em Scopus Scopus - 0 Citations
Other information
Authenticus ID: P-00N-KJ4
Abstract (EN): Background: The presence of impurities in vancomycin compromised the safety and contributed to decrease of its use for years. In Brazil, vancomycin generic drug represents an option to reduce hospital costs. However, the controversy over the quality of these formulations and their relationship to effectiveness and safety raised concerns. Objective and Methods: To assess in vitro quality of vancomycin injections through uniformity of weight, pH, clarity of solution, microbiological assay and impurities determination by High Performance Liquid Chromatography (HPLC). Results: The samples were approved in the tests. Conclusion: The injectable formulations of vancomycin proved to be safe for use in hospital environment. This work contributes to increase health professional's confidence on generic vancomycin.
Language: English
Type (Professor's evaluation): Scientific
No. of pages: 6
Documents
We could not find any documents associated to the publication.
Related Publications

Of the same journal

Risperidone Release from Solid Lipid Nanoparticles (SLN): Validated HPLC Method and Modelling Kinetic Profile (2012)
Another Publication in an International Scientific Journal
Silva, AC; Lopes, CM; Fonseca, J; Soares, ME; Santos, D; Souto, EB; Ferreira, D
Recent trends in high throughput analysis and antioxidant potential screening for phenolics (2008)
Another Publication in an International Scientific Journal
Paula B Andrade; David M Pereira; Federico Ferreres; Patricia Valentao
Meet our editorial board member (2016)
Another Publication in an International Scientific Journal
Paula B Andrade
Fatty Acids in Marine Organisms: In the Pursuit of Bioactive Agents (2011)
Another Publication in an International Scientific Journal
David M Pereira; Juliana Vinholes; Georgina Correia da Silva; Patricia Valentao; Natercia Teixeira; Paula B Andrade
Recent Trends in High Throughput Analysis and Antioxidant Potential Screening for Phenolics (2008)
Article in International Scientific Journal
Paula B. Andrade ; David M. Pereira; Federico Ferreres ; Patrícia Valentao

See all (8)

Recommend this page Top
Copyright 1996-2024 © Faculdade de Engenharia da Universidade do Porto  I Terms and Conditions  I Accessibility  I Index A-Z  I Guest Book
Page generated on: 2024-08-25 at 12:00:38 | Acceptable Use Policy | Data Protection Policy | Complaint Portal